These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9303380

  • 1. Effect of fluconazole on the steady-state pharmacokinetics of delavirdine in human immunodeficiency virus-positive patients.
    Borin MT, Cox SR, Herman BD, Carel BJ, Anderson RD, Freimuth WW.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1892-7. PubMed ID: 9303380
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate.
    Borin MT, Chambers JH, Carel BJ, Gagnon S, Freimuth WW.
    Clin Pharmacol Ther; 1997 May; 61(5):544-53. PubMed ID: 9164416
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients.
    De Wit S, Debier M, De Smet M, McCrea J, Stone J, Carides A, Matthews C, Deutsch P, Clumeck N.
    Antimicrob Agents Chemother; 1998 Feb; 42(2):223-7. PubMed ID: 9527763
    [Abstract] [Full Text] [Related]

  • 10. Metabolism of the HIV-1 reverse transcriptase inhibitor delavirdine in mice.
    Chang M, Sood VK, Wilson GJ, Kloosterman DA, Sanders PE, Hauer MJ, Zhang W, Branstetter DG.
    Drug Metab Dispos; 1997 Jul; 25(7):828-39. PubMed ID: 9224777
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Delavirdine: clinical pharmacokinetics and drug interactions.
    Tran JQ, Gerber JG, Kerr BM.
    Clin Pharmacokinet; 2001 Jul; 40(3):207-26. PubMed ID: 11327199
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Competing drug-drug interactions among multidrug antiretroviral regimens used in the treatment of HIV- infected subjects: ACTG 884.
    Fletcher CV, Acosta EP, Cheng H, Haubrich R, Fischl M, Raasch R, Mills C, Hu XJ, Katzenstein D, Remmel RP, Gulick RM, ACTG Protocol Team.
    AIDS; 2000 Nov 10; 14(16):2495-501. PubMed ID: 11101060
    [Abstract] [Full Text] [Related]

  • 15. Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.
    Smith PF, Dicenzo R, Forrest A, Shelton M, Friedland G, Para M, Pollard R, Fischl M, DiFrancesco R, Morse GD.
    Clin Pharmacokinet; 2005 Nov 10; 44(1):99-109. PubMed ID: 15634033
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Voriconazole and fluconazole increase the exposure to oral diazepam.
    Saari TI, Laine K, Bertilsson L, Neuvonen PJ, Olkkola KT.
    Eur J Clin Pharmacol; 2007 Oct 10; 63(10):941-9. PubMed ID: 17676319
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.